Sglt Inhibitors Explored As Type 1 Diabetes Treatment | Latest News RSS feed

Sglt Inhibitors Explored As Type 1 Diabetes Treatment - Latest News


SGLT2 Inhibitor Amputation Risk Seen in Real-World Diabetes Study

Sodium-glucose cotransporter 2 (SGLT2) inhibitors, increasingly used in the treatment of type 2 diabetes, show as much as a twofold increase in the risks of lower limb amputations and diabetic ketoaci... read more

SGLT2 inhibitors tied to ketoacidosis, limb amputation in diabetics

An observational study of nearly 35,000 Scandinavian patients with type 2 diabetes ... like peptide 1 (GLP1) receptor agonists. In a paper published in The BMJ, senior researcher Bjorn Pasternak, MD, ... read more

SGLT-2i Use in Type 1 Diabetes May Help Maintain Glycemic Levels

The study looked at the introduction of empagliflozin, an SGLT-2 inhibitor for the glycemic control treatment of type 1 diabetes. The majority of people who have type 1 diabetes cannot manage their bl... read more

Looking for another news?


Diabetes Medication Increases Risk of Lower Limb Amputation

SGLT2 inhibitors are increasingly popular drugs for the treatment of type 2 diabetes. They lower blood glucose levels ... SGLT2 inhibitors and 17,213 patients who started taking GLP 1 receptor agonist... read more


Certain diabetes drugs linked to increased risk of lower limb amputation

SGLT2 inhibitors are increasingly popular drugs for the treatment of type 2 diabetes. They lower blood ... of both lower limb amputation (2.7 vs 1.1 events per 1000 person years) and diabetic ... read more

Clinical Challenges: Team Care for Diabetes

High-risk diabetes patients would benefit from getting team-based care from multiple physicians in an approach that would optimize their treatment for cardiac ... Importantly, a protocol for use of SG... read more

Lexicon Likely Looking At Even More Competition In Type 1 Diabetes

Data from Phase III trials of Lilly/Boehringer's Jardiance in Type 1 diabetes supports submission ... for whom there are minimal treatment options beyond insulin therapy (and off-label SGLT-2 inhibito... read more

Rounded approach key to treating diabetes

An abnormal response to insulin distinguishes type 2 diabetes. The production of little to no insulin is associated with type 1, an auto-immune ... called an SGLT2 inhibitor,” adds Dr Al Sibai. read more

SGLT-2 Inhibitors: A New Mechanism for Glycemic Control

Type 2 diabetes is a progressive, chronic metabolic disease characterized by hyperglycemia. 1 Beyond being ... concept of inhibition of SGLT-2 marks a departure in how diabetes is viewed and approache... read more

GLP-1 receptor agonist portfolio offers options for most adults with type 2 diabetes

BOSTON — Among the variety of GLP-1 receptor agonists approved for treatment of type ... for the Study of Diabetes recommended use of SGLT2 inhibitors or GLP-1 receptor agonists with proven CVD benefi... read more

EMPA-HEART: Empagliflozin May Reduce LV Mass in Patients With CVD, Diabetes

CHICAGO — Treatment ... (SGLT2) inhibitor empagliflozin (Jardiance, Boehringer Ingelheim/Lilly) is associated with beneficial effects on left ventricular (LV) structure and function in patients with s... read more

One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo

One class of drug used to treat type 2 diabetes may not reduce ... studied three types of diabetes treatment: sodium-glucose cotransporter 2 (SGLT-2) inhibitors, glucagon-like peptide 1 (GLP-1) agonis... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us